Micron Laboratories Private Limited
Pharmaceutical trading company established in 2012 with headquarters in Gurgaon, Haryana.
2012 | Gurugram, Haryana (India) | Active
Micron Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 13 Year, 2 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 6871.16%
- Profit Growth -12806.72%
- Ebitda -1553.01%
- Net Worth -202.17%
- Total Assets 1026.53%
About Micron Laboratories
Micron Laboratories Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 February 2012 and has a history of 13 years. Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Kumar, Amit Kumar, and Ravi Rajput serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999HR2012PTC045241
- Company No.
045241
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Micron Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Kumar  | Director | 25-Feb-2012 | Current |
| Amit Kumar | Director | 25-Feb-2012 | Current |
| Ravi Rajput | Director | 25-Feb-2012 | Current |
Financial Performance of Micron Laboratories.
Micron Laboratories Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 6871.16% increase. The company also saw a substantial fall in profitability, with a 12806.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 202.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Micron Laboratories?
In 2021, Micron Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Micron Laboratories?
Unlock and access historical data on people associated with Micron Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Micron Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Micron Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.